These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11682931)

  • 1. New strategies in anti-thrombotic therapy offer efficacy, cost savings.
    Clin Resour Manag; 2001 Oct; 2(10):155-8, 145. PubMed ID: 11682931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG
    Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation.
    Huse DM; Cummins G; Taylor DC; Russell MW
    Am J Manag Care; 2002 Jan; 8(1 Suppl):S10-6. PubMed ID: 11822346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep venous thrombosis: outpatient therapy with low-molecular-weight heparin.
    Tapson VF
    Manag Care; 1999 Dec; 8 Suppl():2-6. PubMed ID: 11729399
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-molecular-weight heparin for initial treatment of venous thromboembolism.
    Brewer D
    Am Fam Physician; 2005 Jul; 72(1):75-6. PubMed ID: 16035683
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of pulmonary embolism: The use of low-molecular-weight heparin in the inpatient and outpatient settings.
    Hull RD
    Thromb Haemost; 2008 Mar; 99(3):502-10. PubMed ID: 18327398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of a protocol for the treatment of deep vein thrombosis.
    Spyropoulos AC
    Am J Manag Care; 2001 Nov; 7(17 Suppl):S553-8. PubMed ID: 11732666
    [No Abstract]   [Full Text] [Related]  

  • 8. Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis.
    Couturaud F; Julian JA; Kearon C
    Thromb Haemost; 2001 Oct; 86(4):980-4. PubMed ID: 11686355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-molecular-weight heparin, bemiparin, in the outpatient treatment and secondary prophylaxis of venous thromboembolism in standard clinical practice: the ESFERA Study.
    Santamaría A; Juárez S; Reche A; Gómez-Outes A; Martínez-González J; Fontcuberta J;
    Int J Clin Pract; 2006 May; 60(5):518-25. PubMed ID: 16700847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient treatment of venous thromboembolism using low molecular weight heparins. An overview.
    Matsagas MI
    Int Angiol; 2004 Dec; 23(4):305-16. PubMed ID: 15767978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy.
    Rodger MA; Gagné-Rodger C; Howley HE; Carrier M; Coyle D; Wells PS
    Thromb Res; 2003; 112(1-2):13-8. PubMed ID: 15013267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
    Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring low molecular weight heparins.
    Garon JE
    Clin Leadersh Manag Rev; 2003; 17(1):47-50. PubMed ID: 12592880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of deep vein thrombosis using low-molecular-weight heparins.
    Groce JB
    Am J Manag Care; 2001 Nov; 7(17 Suppl):S510-5; discussion S515-23. PubMed ID: 11732662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of the patient with deep vein thrombosis.
    Weismantel D
    J Fam Pract; 2001 Mar; 50(3):249-56. PubMed ID: 11252215
    [No Abstract]   [Full Text] [Related]  

  • 16. Heparin and low-molecular-weight heparin.
    Gray E; Mulloy B; Barrowcliffe TW
    Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The optimal long-term treatment of venous thromboembolism.
    Prandoni P
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):729-32. PubMed ID: 16170889
    [No Abstract]   [Full Text] [Related]  

  • 18. Clin-IQ project 2006.
    Chitturi S; Muneerah A
    J Okla State Med Assoc; 2007 Dec; 100(12):466-7. PubMed ID: 18251236
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-molecular-weight heparin or oral anticoagulation for secondary prevention of deep vein thrombosis in cancer patients.
    Levine M
    Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():9-11. PubMed ID: 14730472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of low-molecular-weight heparins in the treatment and secondary prevention of cancer-associated thrombosis.
    Grande C; Caparro M
    Semin Oncol Nurs; 2005 Nov; 21(4 Suppl 1):41-9. PubMed ID: 16360897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.